1. Introduction
G protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins, transducing a vast array of extracellular signals into specific cellular responses by activating intracellular signal transduction pathways [
1,
2]. Given their involvement in nearly all physiological and pathophysiological processes and their status as molecular targets for 36% of all approved drugs [
3], a high-resolution analysis of GPCR signaling is of utmost importance. A primary effector system regulated by GPCRs is the adenylyl cyclase (AC) family, where intracellular adenosine 3′,5′-cyclic monophosphate (cAMP) levels are tightly regulated by the opposing actions of G
s proteins leading to cAMP level increases and G
i/o proteins resulting in cAMP level decreases [
4]. This regulatory equilibrium is further refined by the enzymatic activity of phosphodiesterases (PDEs), which catalyze the degradation of cAMP into 5′-AMP. By balancing G protein-mediated synthesis with PDE-mediated hydrolysis, the cell achieves precise spatiotemporal control over intracellular cAMP concentrations. This control is fundamentally rooted in the organization of cAMP signaling into highly localized nanodomains, which prevent the uniform diffusion of this second messenger and ensure that specific GPCR inputs trigger distinct cellular responses [
5].
To monitor these cAMP fluctuations in living cells, Förster resonance energy transfer (FRET)-based sensors have emerged as a powerful alternative to traditional biochemical or radioactive approaches. These optical sensors typically exploit the conformational changes in the exchange protein directly activated by cAMP (Epac), a family of nucleotide exchange factors discovered in 1998 that revealed a signaling mechanism independent of protein kinase A (PKA) [
6,
7]. Structurally, Epac-based sensors consist of a regulatory cAMP-binding domain (CNBD) sandwiched between a donor and an acceptor fluorophore. To prevent interference with endogenous signaling and ensure cytosolic diffusion, the membrane-targeting disheveled-EGL-10-pleckstrin (DEP) domain is removed, and the catalytic guanine nucleotide exchange factor (GEF) domain is often inactivated via point mutations.
The evolution of these sensors [
8,
9,
10] has led to highly optimized FRET constructs such as Epac
H187 [
11], which utilizes a monomeric Turquoise2 [
12] (mTurquoise2, mTq2) as a FRET donor and the tandem dimer of circularly permuted and monomeric Venus (tdVenus) as a FRET acceptor. Featuring an additional amino acid exchange from glutamine to glutamate at position 270 (Q270E) to increase cAMP affinity, Epac
H187 currently represents the most responsive blue-shifted FRET-based cAMP sensor and serves as the benchmark for highest sensitivity and dynamic range [
10].
Besides FRET-based approaches, several genetically encoded single-fluorescent-protein cAMP sensors have recently expanded the available toolbox for live-cell cAMP imaging. These include yellow/green sensors such as Flamindo2 [
13] and G-Flamp1 [
14], red-shifted sensors such as Pink Flamindo [
15] and R-FlincA [
16], and highly sensitive sensors such as cAMPinG1 [
17]. In addition, alternative ratiometric cAMP sensors have been developed, including gCarvi [
18], which is based on the cAMP-binding domain of the bacterial cAMP receptor protein, and optimized Epac-derived FRET/FLIM sensors such as cAMPFIRE [
19]. These sensors differ substantially in their apparent cAMP affinity, dynamic range, spectral properties, and readout principles. Nevertheless, they offer simplified imaging configurations and facilitate multiplex imaging, as cAMP-dependent fluorescence changes can be monitored within a single detection channel. However, unlike FRET-based biosensors, single-fluorophore sensors generally lack an intrinsically ratiometric readout. Consequently, their signals may be more susceptible to variations in sensor expression levels and more strongly affected by photobleaching than those obtained with ratiometric FRET biosensors. In contrast, the intrinsically ratiometric readout of FRET sensors provides an internal normalization that reduces the impact of these experimental factors, thereby facilitating more valid quantitative analysis of intracellular cAMP dynamics [
11]. Altogether, single-fluorophore and FRET-based cAMP biosensors represent complementary approaches with distinct advantages depending on the experimental application.
However, the reliance of the established Epac-based FRET cAMP sensor, such as Epac
H187 [
11], on short-wavelength excitation, particularly around 405 nm for mTurquoise2, poses a significant limitation for advanced experimental settings. Shifting the cAMP sensing technology into the red-shifted spectrum is essential for two primary reasons. First, it ensures compatibility with optogenetics, as the activation spectrum of the bacterial photoactivated adenylyl cyclase (bPAC) overlaps significantly with the excitation wavelengths of blue-shifted donors [
20]. This spectral interference leads to unintended “leak” activation of bPAC during the FRET readout, compromising the independent control of cAMP levels [
20,
21]. Second, it enables simultaneous multi-parameter imaging. For complex signaling assays, it is often necessary to monitor cAMP alongside other messengers, such as calcium (Ca
2+), to understand their intricate cross-talk [
22]. For example, the gold-standard ratiometric calcium indicator Fura-2 requires excitation in the UV/violet range (340/380 nm) [
23]. Simultaneous monitoring of Ca
2+ and cAMP using Fura-2 and Cyan/Yellow FRET sensors (e.g., mTurquoise2/Venus) is hampered by dual spectral crosstalk. Not only the UV excitation used for Fura-2 (340/380 nm) partially excites CFP-like donors due to their broad excitation tails, but, even more critically, the broad emission of Fura-2 (~510 nm) significantly overlaps with both the donor (~480 nm) and acceptor (~530 nm) channels, leading to substantial bleed-through. Utilizing a red-shifted cAMP sensor resolves this by shifting the FRET signals into a transparent spectral “window”, enabling crosstalk-free ratiometric imaging of Ca
2+ and cAMP dynamics within the same single cell.
In this study, we developed and systematically characterized four novel red-shifted Epac-based FRET sensors, Epac
red1, Epac
red2, Epac
red3 and Epac
red4, that exhibit various combinations of yellow, orange, and red fluorescent proteins. These include a tandem dimer form of LanYFP [
24] as well as monomeric variants of Orange2 [
25] and Scarlet3 [
26]. Our goal was to identify a variant that matches the robustness of the Epac
H187 benchmark while offering the spectral flexibility required for multi-modal imaging and optogenetic manipulation. We identified Epac
red4 as a red-shifted lead candidate through pharmacological stimulation and a finely tuned optogenetic approach using a bPAC mutant to demonstrate precise, all-optical control of intracellular cAMP dynamics. Furthermore, we demonstrate that Epac
red4 is well suited for multiplexed imaging, enabling simultaneous and ratiometric monitoring of intracellular Ca
2+ and cAMP dynamics.
2. Materials and Methods
2.1. Chemicals
Poly-L-lysine (Cat. No. P-1524), bovine serum albumin (BSA; Cat. No. A7030), 3-isobutyl-1-methylxanthine (IBMX, Cat. No. I5879) and isoproterenol hydrochloride (Isoprenaline, Cat. No. I6504) were purchased from Sigma-Aldrich (Taufkirchen, Germany). Forskolin (FSK, Cat. No. HY-15371) was obtained from Hölzel Diagnostika Handels GmbH (Köln, Germany). DAMGO (Cat. No. HB2409) was purchased from hellobio (Dunshaughlin, Ireland), and vasoactive intestinal peptide (VIP; Cat. No. 1911) from Bio-Techne GmbH (Wiesbaden-Nordenstadt, Germany). All stock solutions were prepared according to the manufacturers’ instructions, aliquoted, and stored at −20 °C unless stated otherwise. Forskolin was freshly prepared in HEPES-buffered DMEM without phenol red. The end concentration of forskolin is 1 mM for experimental use. For forskolin pre-stimulation with a 1 µM end concentration, a 1 mM stock solution with anhydrous DMSO was prepared, aliquoted, and stored for up to three months. DAMGO was dissolved in double-distilled water to a 200 mM stock solution and used at a final concentration of 200 µM. Isoprenaline was dissolved to a 100 mM stock solution in double-distilled water supplemented with 0.05% sodium metabisulfite (Cat. No. 1.06357, Sigma-Aldrich) to prevent degradation and used at a final concentration of 100 µM. VIP was prepared in double-distilled water to a 10 mM stock solution and used at a final concentration of 10 µM. IBMX was dissolved in anhydrous DMSO to obtain 100 mM and 500 mM stock solutions and used at final concentrations of 100 µM and 500 µM. The final DMSO concentration in all experiments was kept at <2‰. Unless stated otherwise, compounds were applied via bath application at a volume dilution ratio of 1:3, and 10× higher concentrations of maximal effect concentration of receptors, agonists, activators and inhibitors were used to minimize delayed wash-in effects.
2.2. Cell Lines and Culture Conditions
Human embryonic kidney (HEK293T) cells (Leibniz-Institute DSMZ, Braunschweig, Germany; ACC 635) were employed for all experiments. HEK293T cells were maintained in Earl’s Minimal Essential Medium (MEM; Sigma-Aldrich, Taufkirchen, Germany) supplemented with 10% (v/v) fetal calf serum (FCS; Gibco, Life Technologies, Carlsbad, CA, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin. HEK29T cells were maintained at 37 °C in a humidified atmosphere containing 5% CO2.
2.3. FRET-Based cAMP Sensor Architecture
The cytosolic cAMP FRET sensor mTurquoise2-Epac
Q270E-cp173mVenus-cp173mVenus [
11] served as the parental construct. To maintain consistency with existing literature while defining a clear nomenclature for this study, this sensor—frequently cited as H187—is referred to as Epac
H187 throughout this work. The Epac
H187 backbone features a deleted membrane-targeting DEP domain (ΔDEP) and is catalytically inactive due to two point mutations (T781A and F782A) [
27] within the guanine nucleotide exchange factor (GEF) domain, preventing unintended Ras-related protein (Rap) activation. Additionally, a high-affinity amino acid substitution (Q270E) in the cyclic nucleotide-binding domain (CNBD) was utilized to enhance sensitivity toward cAMP. Note that amino acid numbering for all Epac mutations follows the nomenclature of the original Epac-based sensor characterization [
11], independent of the N-terminal fluorophore tags.
2.4. Design and Generation of Red-Shifted Sensor Variants
Four novel red-shifted sensor variants, designated Epac
red1 through Epac
red4, were developed through systematic fluorophore replacement. Primers for site-directed mutagenesis and Gibson assembly were designed using NEBaseChanger and NEBuilder Assembly Tool (New England Biolabs, Ipswich, MA, USA), respectively, and synthesized by Sigma-Aldrich (desalted, 100 μM). Detailed primer sequences and corresponding annealing temperatures are summarized in
Table 1. The first red-shifted variant, Epac
red1 (tdV-Epac-cpmCh2), was generated by replacing the N-terminal mTurquoise2 with circularly permuted, monomeric Cherry2 (cpmCherry2; #52100, Addgene, Watertown, MA, USA) via PCR-based deletion and subsequent ligation, yielding the configuration cp173mVenus-cp173mVenus-Epac
Q270E-cpmCherry2. To create the Epac
red2 (mOrange2-Epac-cpmCh2) variant, both cp173mVenus units were excised and replaced by incorporating monomeric Orange2 (mOrange2; Addgene #54568) at the N-terminus. For the Epac
red3 (tdOrange2-Epac-tdSc3) construct, tandem dimer Scarlet3 (tdScarlet3) was fused to the C-terminus. The mScarlet3 sequence (Addgene #189767) was modified by removing the LifeAct tag and introducing N-terminal NheI and C-terminal EcoRI restriction sites. Following PCR amplification and ligation of two mScarlet3 units, the resulting tdScarlet3 was inserted into the backbone. The N-terminal tandem dimer Orange2 (tdOrange2) was generated by codon-optimizing mOrange2, adding a flexible linker, and fusing it to a second mOrange2 unit before insertion into the EcoRV-digested backbone. Finally, the Epac
red4 (tdLanYFP-Epac-tdSc3) sensor was produced using tandem dimer LanYFP (tdLanYFP) synthesized by GenScript (Piscataway, NJ, USA). The fragment was cloned into the pcDNA3.1(+) vector and subsequently fused to the N-terminus of the Epac backbone via EcoRV digestion.
2.5. Co-Expression Strategies and Optimization
To enable optogenetic control, the red-shifted sensors were co-expressed with the bacterial photoactivated adenylyl cyclase (bPAC). Initially, an internal ribosome entry site (IRES) sequence was utilized downstream of the sensor coding sequence. For the lead candidate Epac
red4 (tdLanYFP-Epac-tdSc3), bPAC was further optimized by introducing the F198Y point mutation. To ensure precise 1:1 stoichiometry and robust expression levels, the IRES sequence was ultimately replaced with a P2A self-cleaving peptide [
28] via PCR-based cloning.
2.6. Imaging Preparation and Transfection
For FRET experiments, cells were seeded onto glass-bottom dishes (FluoroDish, 35 mm diameter, 23 mm glass bottom; WPI, Friedberg, Germany). Prior to seeding, dishes were coated at room temperature with 0.5 mL poly-L-lysine (0.1 mg/mL; Sigma-Aldrich) for 30 min. After removal of the coating solution, dishes were washed once with 2 mL sterile DPBS (Sigma-Aldrich), and cells were seeded in their respective maintenance media. HEK293T cells were transfected with 0.5 μg of the indicated Epac sensor construct, with or without IRES- or -P2A-mediated co-expression of bPAC, using the non-lipid-based reagent GeneJuice® (Merck Millipore, Schwalbach, Germany) according to the manufacturer’s instructions. Where indicated, 1 μg of the human μ-opioid receptor (µOR, pcDNA 3.1+, cDNA Resource Center, #OPRM100000), the human adrenergic β2 receptor (β2R, pcDNA 3.1+, cDNA Resource Center, #AR0B200000), or the vasoactive intestinal peptide receptor 1 (VPAC1R, cDNA Resource Center, #VIPR100000) was co-transfected. All measurements were performed approximately 48 h post-transfection.
2.7. Live-Cell FRET Imaging
Dynamic changes in intracellular cAMP concentrations were quantified in single living cells using the developed red-shifted Epac-based sensors. Imaging was performed at room temperature (22 ± 2 °C) using a laser-coupled, camera-based microscopy system (iMIC2.0, TILL Photonics/FEI, Gräfelfing, Germany) equipped with a Sole-6 Laser Line Combiner (Omicron Laserage Laserprodukte GmbH, Rodgau-Dudenhofen, Germany). This system featured five integrated laser lines: two diode lasers (405 nm/120 mW and 488 nm/100 mW) and three Diode-Pumped Solid-State (DPSS) lasers (515 nm/100 mW, 561 nm/100 mW, and 594 nm/100 mW). The laser lines were coupled into the iMIC2 microscope without the use of an automated fiber switcher to ensure maximum power stability. To virtually eliminate thermal noise and ensure a stable baseline independent of ambient temperature fluctuations, the internal multi-stage Peltier cooling of the back-illuminated EMCCD camera (iXon3 897, model DU-897U-CS0; Andor Technology, Belfast, UK; 512 × 512-pixel sensor with a pixel size of 16 μm) was supplemented with an external water-circulating heat exchanger (LAUDA, Lauda-Königshofen, Germany). The cooling water was maintained at a constant temperature of +14.0 ± 0.1 °C, enabling the EMCCD chip to operate at a highly stable temperature of −95 °C To prevent moisture condensation and ensure stable optical performance at these cryogenic temperatures, the camera port was specifically modified with a custom-built, perforated dehumidification chamber containing a mixture of molecular sieve (5 Å, Carl Roth, Karlsruhe, Germany) and indicator silica gel (red/yellow, grain size 1–3 mm, Carl Roth). Additionally, the interior of the microscope body was dehumidified using permeable pouches filled with the same compounds as those used in the chamber, strategically placed to ensure an unobstructed optical path and unimpeded mechanical movement.
2.8. Image Acquisition, Region of Interest (ROI) Analysis and FRET Quantification
Images were acquired using Live Acquisition software (version 2.5.0.15, TILL Photonics/FEI) at a frequency of 1 Hz with an exposure time of 10 ms per channel. To accommodate filter changes, appropriate switching times were included between channel acquisitions. Camera settings consisted of an EM gain of 20 and 2 × 2-pixel binning to enhance the signal-to-noise ratio. Cells were imaged using a 40× oil-immersion objective (UApo N340, N.A. 1.35, W.D. 0.10 mm; Olympus, Tokyo, Japan). To minimize photobleaching prior to measurements, cell identification and morphology-based selection were performed using low-intensity 594 nm excitation (10%). Fluorophores were excited sequentially using specific laser lines with intensities adjusted for each sensor: mTurquoise2 was excited at 405 nm (100% intensity), while tdVenus, mOrange2, tdOrange2, and tdLanYFP were excited at 515 nm (10–20% intensity). For the red-shifted acceptors, cpmCherry2 was excited at 594 nm (10%), whereas tdScarlet3 was excited at either 561 nm (10%) when paired with tdLanYFP or at 594 nm (60%) when paired with tdOrange2. Emission signals were separated using a 585 nm dichroic beamsplitter.
For data quantification, a single region of interest (ROI) was manually defined for each fusiform cell. These ROIs were strictly confined to the cytoplasmic compartment, carefully excluding the nucleus to ensure a purely cytosolic FRET readout. Depending on individual cell morphology, ROI dimensions typically ranged from 8 to 20 binned pixels (using the 40× objective). Only cells displaying fluorescence intensities 3- to 10-fold above the background (determined in a cell-free area of the imaging field) were included in the analysis.
To account for non-specific signals, mean background intensities measured in the donor (F
Donor), acceptor (F
Acceptor), and FRET (F
FRET) channels were subtracted from the corresponding raw fluorescence intensities. To correct for optical cross-talk, including spectral bleed-through and cross-excitation, normalized FRET (N
FRET) was calculated using a custom-written script in R (version 4.2.3) based on the method described by Xia and Liu (2001) [
29]. Bleed-through coefficients (a and b) were determined using HEK293T cells expressing either the donor or acceptor alone. N
FRET was calculated by subtracting donor and acceptor contributions from the FRET channel and normalizing to the geometric mean of donor and acceptor fluorescence intensities.
Subsequently, N
FRET signals were normalized to baseline by dividing each value by the geometric mean of N
FRET (N
FRETgeom) values recorded between 10 s and 50 s.
Epac
red sensor signals can also be expressed as the simple ratio F
FRET/F
Donor; however, this representation is used exclusively for real-time visualization in the LA software, (version 2.5.0.15) enabling qualitative monitoring and comparison of responses during acquisition. All quantitative analyses in this study are based on N
FRET values corrected according to Xia and Liu (2001) [
29]. A decrease in normalized N
FRET corresponds to an increase in intracellular cAMP levels, reflecting the conformational change in the Epac sensor upon ligand binding. Further data processing, including baseline normalization and statistical analysis, was performed using OriginPro 2026 (OriginLab, Northampton, MA, USA).
2.9. Simultaneous Dual-Parameter Imaging of cAMP and Ca2+
To investigate the spatio-temporal relationship between cAMP and Ca2+ signaling, simultaneous imaging experiments were performed. Intracellular Ca2+ levels were monitored using the ratiometric indicator Fura-2. Cells were loaded with 5 µM Fura-2-acetoxymethyl ester (Fura-2 AM, Invitrogen/Thermo Fisher Scientific, Waltham, MA, USA) in HEPES-buffered Hanks’ Balanced Salt Solution (HBSS) containing 0.1% BSA and 0.04% Pluronic® F-127 for 30 min at 37 °C in a humidified atmosphere containing 5% CO2, followed by three wash steps with 2 mL HBSS each to allow for complete de-esterification of the dye.
Dual-parameter imaging was achieved by synchronizing the laser-based iMIC2.0 FRET setup with a Polychrome V illumination system (TILL Photonics/FEI, Munich, Germany) equipped with a 150 W xenon arc lamp. Cells were imaged using a 20× UV-transmissive oil-immersion objective (UPlanSApo 20× Oil, N.A. 0.85, W.D. 0.20 mm; Olympus, Tokyo, Japan; system FN 26.5) mounted on the iMIC system, which enabled both Fura-2 and FRET measurements. Fura-2 fluorescence was excited alternately at 340 nm and 380 nm, and emission was collected at 510 nm. To prevent spectral overlap between the Fura-2 emission and the FRET donor signal, a specialized multiband dichroic beamsplitter and high-performance emission bandpass filters (510/20 nm for Fura-2 and 470/24 nm for mTurquoise2) were utilized.
Acquisition was strictly interleaved, ensuring that the UV excitation for Fura-2 (340/380 nm) and laser excitation for FRET were performed in rapid succession to avoid simultaneous fluorescence emission and minimize crosstalk. To further evaluate potential spectral crosstalk, the excitation spectra of the employed fluorophores were considered during experimental design. While tdLanYFP exhibits an excitation maximum in the green spectral range at 513 nm, excitation at 340 nm was not detectable under our imaging conditions, and excitation at 380 nm was negligible. Conversely, Fura-2 fluorescence was exclusively recorded during UV excitation periods and detected through dedicated emission filters centered at 510 nm. Together with the sequential acquisition protocol, this ensured effective optical and temporal separation of the cAMP and Ca2+ signals.
Crucially, identical ROIs were used for FRET and Fura-2 analysis to ensure precise spatial co-registration of both second messengers. A single cytoplasmic ROI per cell was selected, excluding the nucleus, and typically comprised 5–12 binned pixels depending on cell morphology (using the 20× objective). Acquisition was interleaved with the FRET protocol, ensuring near-simultaneous recording of both second messengers. According to the Grynkiewicz method (1985) [
23], intracellular Ca
2+ concentrations were expressed as the ratio of fluorescence intensities (R = F
340/F
380). Background subtraction was performed for both wavelengths (340 nm and 380 nm) prior to ratio calculation. This combined optical and temporal separation ensured a crosstalk-free, near-simultaneous recording of both second messengers under stable physiological conditions. Measurements were performed in HEPES-buffered saline (HBS) solution containing 140 mM NaCl, 5.4 mM KCl, 1 mM MgCl
2, 2 mM CaCl
2, 10 mM glucose, and 10 mM HEPES (pH 7.4 adjusted with NaOH; osmolarity 295–302 mOsm kg
−1).
2.10. Quantification and Statistical Analysis
Statistical analyses were performed in Origin 2026 (OriginLab Corporation, Northampton, MA, USA) using an unpaired Mann–Whitney U test, Kruskal–Wallis test, paired Wilcoxon matched-pairs signed-rank test followed by post hoc Dunn’s test, or Friedman test followed by post hoc Dunn’s test where appropriate. A p value < 0.05 was considered statistically significant. Significance levels were defined as * p < 0.05, ** p < 0.01, and *** p < 0.001. Box plots represent the median and interquartile range. The specific statistical tests used are indicated in the respective figure legends.
4. Discussion
Cellular signaling relies on the intricate interplay between second messengers, with Ca
2+ and cAMP acting as ubiquitous and central regulators [
32], embedded within a broader network of key mediators including IP
3, DAG, and cGMP that collectively orchestrate cellular viability. Rather than acting in isolation, these messengers form a tightly coupled, interdependent signaling network. As is well established, Ca
2+ levels shape cAMP dynamics via Ca
2+-regulated adenylyl cyclases and phosphodiesterases, while cAMP-dependent protein kinase A reciprocally modulates Ca
2+ influx and release. This bidirectional cross-talk is essential for generating complex signaling regimes such as the synchronized oscillations in pancreatic β-cells [
33,
34] or synaptic plasticity in neurons [
35]. Measuring only one parameter provides a fragmentary view that can lead to a fundamental misinterpretation of the cellular state. The ability to monitor Ca
2+ and cAMP simultaneously in the same cell is therefore essential for uncovering the causal relationships and phase shifts that define physiological homeostasis. For example, in pancreatic β-cells, the precise timing between Ca
2+ oscillations and cAMP transients determines insulin secretion [
36], while in neurons, coordinated Ca
2+/cAMP dynamics underlie the induction of long-term potentiation and synaptic plasticity [
37,
38].
Despite the scientific demand, multiparametric imaging of cAMP alongside Ca
2+ has been hindered by significant physical and optical constraints. Traditional CFP/YFP-based FRET sensors occupy the most vital part of the visible spectrum and create massive spectral overlap with established green Ca
2+ indicators like the GCaMP family, making simultaneous imaging challenging. Likewise, the combination of CFP/YFP-based FRET sensors with the synthetic dye Fura-2 is problematic due to overlapping fluorescence emissions [
39]. While the mOrange2-mCherry FRET pair has been successfully implemented to enable dual-FRET imaging in complex live-cell contexts, for example, concurrent Src and MT1-MMP activity mapping in single cells [
40], significant spectral crosstalk between mOrange2 and mCherry remains, often narrowing the effective dynamic range of the sensors [
41]. Red-shifted fluorescent proteins have historically lagged behind their green counterparts in quantum yield and brightness, which can limit sensor sensitivity and necessitate higher excitation intensities that increase phototoxicity and bleaching [
42]. Engineering strategies aimed at enhancing dynamic range and photostability of red FRET pairs, including self-associating domain designs, illustrate one solution to these limitations but often still fall short of the performance needed for robust multiparametric imaging [
43]. Although extending the sensing range further into the near-infrared would mitigate spectral overlap with visible Ca
2+ indicators [
44], this typically entails substantial technical effort to adapt excitation sources and detection hardware, which is not commonly implemented in standard imaging setups.
Our findings suggest that Epacred4 showed the most robust performance among the red-shifted variants. Notably, the utilization of mOrange2 as a FRET donor in Epacred2 and Epacred3 proved less effective than the use of tdLanYFP in Epacred4. One reason for this might be its high pKa of 6.5 compared to the significantly more acid-stable 3.9 of tdLanYFP. This pH sensitivity is particularly pronounced in the tandem variant Epacred3, which exhibited twice the variance in NFRET decreases under both maximally endogenous and light-induced bPAC activation. This might reflect a compounded pH dependency inherent to the doubled pKa in the tandem construct. Beyond its suboptimal acid stability, mOrange2 is further constrained by a lower quantum yield of 0.6 and a brightness of 34.8. These values fail to match the superior performance of tdLanYFP, which offers a quantum yield of 0.92 and a brightness of 122.4. While the mOrange2-mCherry pair was successfully implemented in complex imaging scenarios, significant crosstalk remains a major drawback that narrows the dynamic range of the sensor.
In contrast, tdScarlet3 represents a substantial technological advancement with an exceptional quantum yield of 0.70 and a brightness nearly three times that of mCherry2. This significantly enhances the signal-to-noise ratio in the FRET channel. The excitation maximum of mScarlet3 at 569 nm provides a superior spectral overlap with the mOrange2 emission compared to mCherry2. This results in a larger Förster radius and increased energy transfer efficiency. Coupled with its superior acid stability, tdScarlet3 is far superior as an acceptor for robust biosensor design. Provided that the quantum yield and pKa of mOrange2 could be further optimized in a next-generation “mOrange3”, a sophisticated dual-FRET architecture would become possible. Pairing an optimized mOrange3 with tdScarlet3 would establish a system that exhibits minimal spectral excitation overlap with established mTq2-tdVenus FRET pairs.
This streamlined approach facilitates the simultaneous recording of cAMP dynamics in distinct subcellular nanodomains via targeted Epac sensors. Furthermore, this strategy allows for the integration of modern mTurquoise2-cpmVenus Cameleon sensors for ratiometric calcium imaging alongside mOrange3-based cAMP sensors, which offers a powerful and purely genetically encoded alternative to traditional Fura-2-based multiplexing. The addition of the blue-light-activated adenylyl cyclase bPAC
F198Y transforms this observational setup into a causal platform. Beyond demonstrating spectral compatibility, this all-optical configuration enables temporally precise perturbation of cAMP levels. Furthermore, we could show that Epac
red4 can be particularly useful for analyzing recovery kinetics and phosphodiesterase-dependent signal shaping (
Figure 6). However, future studies with targeted bPAC pulses combined with subtype-specific PDE inhibitors might enable a deeper understanding of how specific enzyme isoforms guard individual nanodomains.
The practical utility of Epac
red4 is most notably demonstrated by its seamless integration into multiplexed imaging protocols. While traditional blue-shifted sensors often restrict the available spectral space, the red-shifted profile of Epac
red4 enables the use of the ratiometric Ca
2+ indicator Fura-2 with minimal spectral interference. This is a critical advantage, as Fura-2 remains a gold standard for quantitative Ca
2+ imaging due to its ratiometric nature, yet it was previously difficult to combine with CFP/YFP-based cAMP sensors. Our simultaneous recordings of cAMP and Ca
2+ (
Figure 5E,F) reveal the power of this combination in dissecting complex GPCR signaling signatures. The observation of a rapid Ca
2+ transient following β
2AR activation—typically regarded as a G
s protein-coupled event—highlights the ability of this GPCR to capture nuanced signaling crosstalk. As recently elucidated by De Pascali et al. (2024) [
31], the β
2AR can promote agonist-dependent G
q protein coupling, particularly in overexpression systems. By resolving both the G
s protein-driven cAMP rise and the G
q protein-mediated Ca
2+ mobilization in the same cell, Epac
red4 provides a comprehensive readout of receptor pleiotropy. The fact that subsequent AT
1R activation triggered a further Ca
2+ peak without perturbing the established cAMP plateau further underlines the independence and robustness of our dual-parameter setup. This capability is essential for studying “signal-tuning”, where multiple G protein pathways converge to shape the final cellular response. Future experiments investigating endogenously expressed receptors in native cells using multiplexing approaches might help unravel the complex interplay between cAMP and Ca
2+ signaling.
Besides spectral properties and dynamic range, the cAMP affinity is an important criterion when selecting a genetically encoded cAMP biosensor. Epac
red4, which is based on Epac
H187, retains the Epac sensing domain, including the Q270E mutation, previously reported to decrease the K
d from approximately 9.5 µM to 4.0 µM, thereby increasing cAMP affinity by about 2.5-fold [
11]. Since the cAMP-binding domain of Epac
red4 was not modified, its cAMP-binding affinity is expected to remain comparable to that of Epac
H187, with an apparent K
d in the single-digit micromolar range. However, because the fluorescent protein pair was redesigned, the exact K
d of Epac
red4 cannot be inferred directly and must be determined experimentally. Indeed, changes in the fluorescent proteins may alter the conformational coupling within the biosensor and thereby affect its apparent affinity and overall sensor properties.
Recently developed genetically encoded cAMP biosensors exhibit a broad range of apparent cAMP affinities and employ different optical readout principles. Among currently available sensors, apparent K
d values range from the hundreds of nanomolar range to the single-digit micromolar range. cAMPinG1 [
17] and R-FlincA [
16] exhibit apparent K
d values in the hundreds of nanomolar range, whereas G-Flamp1 [
14], Flamindo2 [
13], Pink Flamindo [
15], gCarvi [
18], and Epac-based FRET sensors [
11] including cAMPFIRE [
19] operate in the single-digit micromolar range. Sensors in the hundreds of nanomolar range are particularly well suited for detecting small or basal changes in cAMP but may approach saturation during strong receptor stimulation or pharmacological elevation of cAMP. In contrast, sensors operating in the single-digit micromolar range provide a broader working range for monitoring large cAMP elevations and their subsequent recovery. Thus, the optimal biosensor depends on the expected intracellular cAMP concentrations and the biological question being addressed.
In addition to affinity, the optical design of a biosensor is an important consideration. Single-fluorescent-protein sensors, including cAMPinG1 [
17], G-Flamp1 [
14], Flamindo2 [
13], Pink Flamindo [
15], and R-FlincA [
16], require relatively simple imaging setups, whereas Epac
H187, cAMPFIRE, and Epac
red4 are FRET-based biosensors that provide internally normalized ratiometric readouts [
11,
19]. gCarvi represents an alternative ratiometric design based on the bacterial cAMP receptor protein [
18]. However, currently optimized Epac-derived FRET sensors largely rely on cyan/yellow fluorescent protein pairs, limiting their compatibility with blue-light optogenetic actuators such as bPAC and UV-excited indicators such as Fura-2. Epac
red4 addresses this limitation by replacing the conventional cyan/yellow FRET pair with a yellow/red FRET pair while preserving ratiometric detection, thereby enabling quantitative multiparameter imaging with substantially reduced spectral overlap.
To summarize, our findings solidify Epacred4 as a premier high-fidelity benchmark that transcends simple detection and provides a high-resolution window into the fundamental robustness of cellular homeostasis. Furthermore, our findings identify Epacred4 as a robust red-shifted cAMP sensor that combines quantitative FRET readout with spectral compatibility for optogenetic stimulation and simultaneous multiparameter imaging. Future studies should determine how well Epacred4 performs in more physiologically relevant systems and whether it can be adapted to resolve highly localized cAMP nanodomains in subcellular compartments.